Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
56
KPT.TO Quote, Financials, Valuation and Earnings
Last price:
$10.25
Seasonality move
:
-1.53%
Day range:
$10.31 - $10.48
52-week range:
$7.54 - $10.50
Dividend yield:
6.89%
P/E ratio:
26.88x
P/S ratio:
1,406.61x
P/B ratio:
1.50x
Volume:
11.7K
Avg. volume:
15.7K
1-year change:
27.59%
Market cap:
$104.6M
Revenue:
--
EPS (TTM):
$0.39
Analysts' Opinion
-
Consensus RatingKP Tissue, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.50, KP Tissue, Inc. has an estimated upside of 0.48% from its current price of $10.45.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.00 representing 100% downside risk from its current price of $10.45.
Fair Value
-
According to the consensus of 4 analysts, KP Tissue, Inc. has 0.48% upside to fair value with a price target of $10.50 per share.
KPT.TO vs. S&P 500
-
Over the past 5 trading days, KP Tissue, Inc. has underperformed the S&P 500 by -1.22% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
KP Tissue, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
KP Tissue, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter KP Tissue, Inc. reported revenues of --.
Earnings Growth
-
KP Tissue, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter KP Tissue, Inc. reported earnings per share of $0.15.
Enterprise value:
104.6M
EV / Invested capital:
1.50x
Price / LTM sales:
1,406.61x
EV / EBIT:
--
EV / Revenue:
1,408.14x
PEG ratio (5yr expected):
--
EV / Free cash flow:
60.28x
Price / Operating cash flow:
60.21x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
5.45%
Net Income Margin (TTM):
--
Return On Equity:
5.6%
Return On Invested Capital:
5.6%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$0.79 | $0.64 | $0.39 | $0.21 | $0.15 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9M | $2.4M | $2.2M | $2.2M | $1.8M | |
| Total Assets | $81.9M | $93.1M | $74.6M | $72.9M | $71.3M | |
| Current Liabilities | $3.3M | $2M | $1.8M | $2.2M | $1.8M | |
| Total Liabilities | $4.3M | $9.3M | $1.8M | $2.2M | $1.8M | |
| Total Equity | $77.5M | $83.8M | $72.7M | $70.7M | $69.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $10.5M | $7M | $1.7M | $1.7M | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -$7M | -$7M | -$7M | -$1.7M | -$1.7M | |
| Free Cash Flow | $10.5M | $7M | $1.7M | $1.7M | -- | |
KPT.TO
Sector
Market Cap
$104.6M
$125M
Price % of 52-Week High
99.52%
70.51%
Dividend Yield
6.89%
0%
Shareholder Yield
7.62%
2.3%
1-Year Price Total Return
27.6%
-7.14%
Beta (5-Year)
0.258
0.255
Dividend yield:
6.89%
Annualized payout:
$0.72
Payout ratio:
116.2%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$10.39
200-day SMA
Buy
Level
$9.11
Bollinger Bands (100)
Buy
Level
9.27 - 10.07
Chaikin Money Flow
Buy
Level
444K
20-day SMA
Buy
Level
$10.39
Relative Strength Index (RSI14)
Buy
Level
63.47
ADX Line
Buy
Level
25.41
Williams %R
Sell
Level
-13.5135
50-day SMA
Buy
Level
$9.86
MACD (12, 26)
Buy
Level
0.14
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
363.6K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (25.1391)
Buy
CA Score
(Annual)
Level (1.6987)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-3.3394)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
KP Tissue, Inc. operates as a holding company. It engages in the production, distribution, marketing and sale of tissue products. The firm's products include bathroom tissue, facial tissue, paper towels and napkins, for both the consumer and the away-from-home market. It operates through two segments: Away-From-Home and Consumer. The Away-From-Home segment includes the Purex, Esteem, White Swan, Embassy and Chalet brands. The Consumer segment operates through the following brands: Cashmere, Purex, Scotties, SpongeTowels and White Cloud. The company was founded on October 1, 2012 and is headquartered in Mississauga, Canada.
Stock Forecast FAQ
In the current month, KPT.TO has received 0 Buy ratings 4 Hold ratings, and 0 Sell ratings. The KPT.TO average analyst price target in the past 3 months is $10.50.
-
Where Will KP Tissue, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that KP Tissue, Inc. share price will rise to $10.50 per share over the next 12 months.
-
What Do Analysts Say About KP Tissue, Inc.?
Analysts are divided on their view about KP Tissue, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that KP Tissue, Inc. is a Sell and believe this share price will drop from its current level to $10.00.
-
What Is KP Tissue, Inc.'s Price Target?
The price target for KP Tissue, Inc. over the next 1-year time period is forecast to be $10.50 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is KPT.TO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for KP Tissue, Inc. is a Hold. 4 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of KPT.TO?
You can purchase shares of KP Tissue, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase KP Tissue, Inc. shares.
-
What Is The KP Tissue, Inc. Share Price Today?
KP Tissue, Inc. was last trading at $10.25 per share. This represents the most recent stock quote for KP Tissue, Inc.. Yesterday, KP Tissue, Inc. closed at $10.45 per share.
-
How To Buy KP Tissue, Inc. Stock Online?
In order to purchase KP Tissue, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get KPT.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KPT.TO
Sector
P/E ratio
26.88x
16.73x
PEG ratio
--
0.13x
P/B ratio
1.50x
1.49x
Price / LTM sales
1,406.61x
0.51x
Growth Metrics
KPT.TO
Sector
Revenue growth
--
2.99%
Earnings growth
-25.96%
5%
Revenue (5-year growth)
--
3.31%
Earnings forecast
$0.14
$0.32
Profitability
KPT.TO
Sector
Profitability FY 2024
--
$263.1M
Return on invested capital
5.6%
4.37%
Return on assets
5.45%
3.04%
Return on equity
5.6%
7.5%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
4
Estimated Next Earnings Date
Feb
12
Balance Sheet
KPT.TO
Sector
Total cash
--
$87.3M
Short term investments
--
$32.9M
Total assets
$71.3M
$1.1B
Long term debt
--
$6.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
